NORD comments to FDA regarding its proposed rule on importation
Published: Mar 9, 2020
Tagged in: Access to Innovative Medicines and Therapies, Protecting FDA Standards for Safe and Effective Drugs
For decades, NORD has pursued federal and state policies that will change the lives of Americans impacted by rare diseases for the better. NORD’s work can be viewed below. This page is updated daily to provide timely information. Please contact us if you have questions or need additional information.
NORD comments to FDA regarding its proposed rule on importation
Published: Mar 9, 2020
Tagged in: Access to Innovative Medicines and Therapies, Protecting FDA Standards for Safe and Effective Drugs
NORD comments on the Conditional Approval Act
Published: Feb 3, 2020
Tagged in: Access to Innovative Medicines and Therapies, Protecting FDA Standards for Safe and Effective Drugs
NORD sign-on letter from over 30 rare disease organizations in support of Dr. Stephen Hahn, the nominee for FDA Commissioner
Published: Dec 2, 2019
Tagged in: Access to Innovative Medicines and Therapies, Protecting FDA Standards for Safe and Effective Drugs
Coalition letter to the Administration regarding the potential of a recent memo to hamper FDA
Published: Apr 26, 2019
Tagged in: Access to Innovative Medicines and Therapies, Protecting FDA Standards for Safe and Effective Drugs
Coalition comments to the President and Congress outlining the detrimental impact of the shutdown on FDA and asking for it to be brought back to its full capacity
Published: Jan 23, 2019
Tagged in: Access to Innovative Medicines and Therapies, Protecting FDA Standards for Safe and Effective Drugs
Alliance for a Stronger FDA letter to Congress regarding FDA appropriations
Published: Jul 10, 2018
Tagged in: Appropriations, Access to Innovative Medicines and Therapies, Protecting FDA Standards for Safe and Effective Drugs